Long-acting GHRH analog
CJC-1295
Matched on: name
CJC-1295 is a modified growth-hormone-releasing hormone analog designed to resist enzymatic degradation and, in its drug-affinity-complex form, bind circulating albumin. Early studies show prolonged stimulation of growth hormone and IGF-1, but biomarker elevation is not equivalent to demonstrated clinical benefit.
Evidence and record details
Evidence integrity map
- Publication state
- Published profile
- Verified source records
- 25 source records verified
- Chemistry record
- Chemistry record on file
- Regulatory entries
- 2 published regulatory entries
- Research questions
- 24 open research questions
- Evidence review date
- No documented human review recorded
Source verification checks records; it does not itself approve scientific conclusions.